FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), today announced the issuance of a new patent by the European Patent Office covering the use of multiple classes of drugs in oral sprays. European Patent No. 1,275,374 covers the use of analgesics, alkaloids and nicotine for the preparation of buccal sprays with non-polar solvents that would be absorbed through the oral mucosa. The patent is applicable in 17 countries throughout Europe for a term of twenty years.
